2023 Fourth-Quarter reported sales growth of 7.3% to $21.4 Billion with operational growth of 7.2% and adjusted operational growth of 5.7% . Operational growth excluding COVID-19 Vaccine of.
2023 Third-Quarter reported sales growth of 6.8% to $21.4 Billion with operational growth of 6.4% and adjusted operational growth of 4.9% . Operational growth excluding COVID-19 Vaccine of.
2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5% and adjusted operational growth of 6.2% . Operational growth excluding COVID-19 Vaccine of.
2023 First-Quarter reported sales growth of 5.6% to $24.7 Billion with operational growth of 9.0% and adjusted operational growth of 7.6%
2023 First-Quarter basic loss per share of decreasing. | April 18, 2023
Total sales growth of 5.0% to $23.4 Billion with operational growth of 7.7% and adjusted operational growth of 7.9% Earnings per share of $1.93 decreasing 16..